INBX

INBX Operating Income Growth

23.47%TTM

Period ending:

INBX TTM Operating Income YoY %%
INBX TTM Operating Income YoY %83.94%-171.07%
2019-12-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

INBX operating income growth history

Year-over-year operating income growth rate. The available trailing twelve months (ttm) series contains 27 observations from Dec 31, 2019 to Jun 30, 2026.

Inhibrx Biosciences Inc Operating Income Growth — Trailing twelve months (TTM)
Period endingOperating Income Growth
23.4733%
59.0545%
59.2621%
58.3488%
54.7187%
-20.5568%
-51.1935%
-122.1983%
-144.9%
-73.2724%
-69.7664%
-47.2133%
-47.868%
-65.2549%
-68.6135%
-52.2278%
-43.4065%
-27.2949%
-13.5537%
-15.9896%
-15.4524%
-24.4541%
-64.6839%
-104.2914%
-146.3874%
-136.2105%
-48.7037%

Compare operating income growth

All INBX financial metrics · INBX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.